Van ECK Associates Corp trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 18.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,407,227 shares of the medical research company’s stock after selling 310,807 shares during the period. Van ECK Associates Corp’s holdings in Agilent Technologies were worth $186,922,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Core Wealth Advisors LLC bought a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $26,000. SHP Wealth Management bought a new position in Agilent Technologies in the 4th quarter valued at approximately $26,000. Navalign LLC purchased a new stake in Agilent Technologies during the 4th quarter valued at $27,000. Cedar Mountain Advisors LLC bought a new stake in shares of Agilent Technologies in the 1st quarter worth $27,000. Finally, MV Capital Management Inc. bought a new stake in shares of Agilent Technologies in the 4th quarter worth $28,000.
Agilent Technologies Stock Down 2.0%
Shares of A stock opened at $154.47 on Friday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $163.75. The stock has a market cap of $43.63 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.72 and a beta of 1.25. The company has a current ratio of 2.05, a quick ratio of 1.62 and a debt-to-equity ratio of 0.50. The company has a 50 day simple moving average of $140.30 and a two-hundred day simple moving average of $127.04.
Key Agilent Technologies News
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
- Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
- Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
- Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on A. JPMorgan Chase & Co. upped their price target on Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a report on Thursday. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. TD Cowen upped their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Piper Sandler started coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $170.33.
Read Our Latest Research Report on Agilent Technologies
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
- Five stocks we like better than Agilent Technologies
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
